| Cases |
Age (yo) |
Gender |
Histology |
Path Staging |
Initial tumor size
(cm) |
Final
Tumor size (cm) |
%
Difference |
Path Staging |
| 1 |
63 |
Male |
RCC-CC |
pT2N0 |
16.07 |
15.59 |
-3% |
pT2pN0 |
| 2 |
46 |
Female |
RCC-CC |
pT3aN0 |
16.52 |
13.15 |
-20% |
pT3apN0 |
| 3 |
55 |
Female |
RCC-Papillary |
pT2aN0 |
15.11 |
10.05 |
-33.5% |
pT2apN0 |
| 4 |
45 |
Female |
RCC-XP11.2 |
pT2aN0 |
14.32 |
14.74 |
+3.0% |
pT2apN0 |
| 5 |
51 |
Female |
RCC-CC |
pT2aN0 |
18.34 |
15.25 |
-16.8% |
pT2apN0 |
| controls |
|
| 1 |
61 |
Male |
RCC-CC |
pT1bN0 |
6.00 |
|
|
|
| 2 |
62 |
Male |
RCC-CC |
pT2N0 |
9.50 |
|
|
|
| 3 |
68 |
Male |
RCC-CC |
pT1aN0 |
3.50 |
|
|
|
| 4 |
57 |
Male |
RCC-CC |
pT2N2 |
8.50 |
|
|
|
| 5 |
59 |
Male |
RCC-CC |
pT3bN0 |
10.50 |
|
|
|
| 6 |
59 |
Female |
RCC-CC |
pT3aN0 |
15.60 |
|
|
|
| RCC: Renal Cell Carcinoma; CC: Clear Cell |
|
